Quest Partners LLC Denali Therapeutics Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Quest Partners LLC holds 25,060 shares of DNLI stock, worth $342,570. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,060
Previous 6,961
260.01%
Holding current value
$342,570
Previous $142 Million
140.15%
% of portfolio
0.04%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$180 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$165 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$161 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$156 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$92.5 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.83B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...